Clearside Biomedical (CLSD) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts CLSD Hot Sheet
Join SI Premium – FREE
Clearside Biomedical (NASDAQ: CLSD) reported Q3 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $260 thousand versus the consensus estimate of $410 thousand.
For earnings history and earnings-related data on Clearside Biomedical (CLSD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
- PPL Corp. (PPL) Misses Q2 EPS by 4c
- bioAffinity (BIAF) Tops Q2 EPS by 146c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
